128 results
Page 4 of 7
8-K
EX-99.1
s71tblu
11 Feb 20
FibroGen Announces U.S. FDA Acceptance of New Drug Application for Roxadustat for the Treatment of Anemia of Chronic Kidney Disease
5:16pm
8-K
EX-99.1
07bx7268mmcf
30 Jan 20
Astellas Submits Supplemental New Drug Application for Approval of
4:40pm
8-K
EX-99.1
xsg4 mc7w
13 Jan 20
Regulation FD Disclosure
9:01am
8-K
EX-99.1
xnhvk1kud
6 Jan 20
Fibrogen Names Enrique Conterno As Chief Executive Officer
5:23pm
8-K
EX-99.1
pk5goqcz
23 Dec 19
Fibrogen Submits New Drug Application to the U.S. Fda for Roxadustat In Patients with Anemia of Chronic Kidney Disease
9:06am
8-K
EX-99.1
d55zlt 5j
2 Dec 19
FibroGen Announces Roxadustat Inclusion in China’s National Reimbursement Drug List
7:10am
8-K
EX-99.1
2t3rhs uanowj
12 Nov 19
FibroGen Reports Third Quarter 2019 Financial Results
8:16am
8-K
EX-99.2
oy9m02xxd8 win
12 Nov 19
FibroGen Reports Third Quarter 2019 Financial Results
8:16am
8-K
EX-99.1
obnyabsd 6uy18t8a0f4
8 Nov 19
Regulation FD Disclosure
2:05pm
8-K
EX-99.1
sgq543
8 Nov 19
FibroGen Announces Positive Phase 3 Pooled Roxadustat Safety and Efficacy Results for Treatment of Anemia in Chronic Kidney Disease
2:00pm
8-K
EX-99.1
76ena7kuvwvw4t7nm
11 Oct 19
Regulation FD Disclosure
11:49am
8-K
EX-99.1
jk7m546cv2nyc8fztp
26 Sep 19
FibroGen Announces Initiation of Phase 2 Clinical Trial of Roxadustat for the Treatment
9:01am
8-K
EX-99.1
4v1oz
20 Sep 19
Roxadustat Approved in Japan for the Treatment of Anemia Associated with Chronic Kidney Disease in Dialysis Patients
9:00am
8-K
EX-99.1
xmanv1zf
26 Aug 19
Departure of Directors or Certain Officers
9:04am
8-K
EX-99.1
1h4qdpe
21 Aug 19
Roxadustat Approved In China for Treatment of Anemia In Chronic Kidney Disease Patients Not Receiving Dialysis
4:39pm
8-K
EX-99.1
3v84b4
8 Aug 19
Fibrogen Reports Second Quarter 2019 Financial Results
4:15pm
8-K
EX-99.1
9aj rtbs04wvb2g
24 Jul 19
Other Events
9:46pm
8-K
EX-99.2
ow26i xxl
24 Jul 19
Other Events
9:46pm